Altimmune (ALT) Return on Capital Employed Growth (1y) (2012 - 2026)
Altimmune (ALT) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 469.79 Bn | 465.00 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.62 Bn | 62.62 Bn | - | - |
| 8 | Argenx Se | 56.18 Bn | 50.99 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -3,457.00 |
| 10 | Altimmune | 354.72 Mn | 354.72 Mn | - | 3,821.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,821.00 |
| Dec 31, 2025 | 3,716.00 |
| Sep 30, 2025 | 2,649.00 |
| Jun 30, 2025 | 887.00 |
| Mar 31, 2025 | -1,725.00 |
| Dec 31, 2024 | -2,314.00 |
| Sep 30, 2024 | -2,128.00 |
| Jun 30, 2024 | -1,579.00 |
| Mar 31, 2024 | -422.00 |
| Dec 31, 2023 | -1,028.00 |
| Sep 30, 2023 | -846.00 |
| Jun 30, 2023 | -36.00 |
| Mar 31, 2023 | 314.00 |
| Dec 31, 2022 | 216.00 |
| Sep 30, 2022 | -720.00 |
| Jun 30, 2022 | -2,272.00 |
| Mar 31, 2022 | -2,712.00 |
| Dec 31, 2021 | -2,210.00 |
| Sep 30, 2021 | -676.00 |
| Jun 30, 2021 | 2,889.00 |